A carregar...
Salvage therapy for hepatocellular carcinoma with thalidomide
AIM: To evaluate the clinical benefit of thalidomide in patients with advanced hepatocellular carcinoma (hepatoma). METHODS: From March 2000 to July 2002, patients who had advanced hepatocellular carcinoma and failed to or were unsuited for aggressive treatment, were enrolled and took thalidomide 15...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716902/ https://ncbi.nlm.nih.gov/pubmed/14991931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i5.649 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|